Blue Horseshoe Stocks: Options Reviews

CarMax, Inc, KMX – Recap

Yesterday morning we placed a set of contracts from the KMX chain on our radars, and while we didn’t yet see a clean sweep of gains from bottom to top, the beginnings of some really nice activity did take place in the lower end of the range.

We had designated the KMX Weekly $77-79 Calls as our contracts of interest and the 77-78′s came alive for some excellent intraday moves.

$77 Calls
– Range: .10-.85 – Max Gain: 750%
$77.50 Calls – Range: .11-.60 – Max Gain: 445%
$78 Calls – Range: .05-.40 - Max Gain: 700%


Adobe Systems, Inc. ADBE – Recap

We included an idea for the Adobe options chain on Monday morning, and have also seen some very nice gains there as well this week. This all three of our targets, the ADBE 10/26 $260-265 Calls have produced chances at big-time multibag gains over the past three sessions.

We reported nominal gains on Tuesday morning, but after an extra couple of trading days, we’ve seen those ranges extended by a considerable margin.

$260 Calls– Range: 8.05-14.28 – Max Gain: 77%
$262.50 Calls – Range: 7.25-12.93 – Max Gain: 78%
$265 Calls – Range: 4.85-9.90 – Max Gain: 104%


Extended Watchlist: 
CEI, AMRS, UPL, AMDA, GWPU, YUMA, AWSM

Blue Horseshoe Stocks: CGC Bull Run Continues

Canopy Growth Corp. CGC

Ever since Constellation Brands’ (STZ) added a multi-billion dollar block to its stake in CGC, the corresponding options idea we put out on Wednesday morning  continues to pile on new highs.

Our designated targets were the CGC 09/21 $30-40 Calls, which as of yesterday morning had already produced chances at gains ranging from 150-350% Those ranges were extended by a wide margin thanks to yesterday’s activities.

$30 Calls – Range: 1.76-7.70 – Max Gain: 338%
$35 Calls – Range: .56-3.90 – Max Gain: 596%
$40 Calls – Range: .16-1.75 – Max Gain: 994%

(Note: The 32.50 and 37.50 calls didn’t trade much volume until yesterday session, where they too produced sizable gains)
________

Fresh Ideas:
TJX 09/21 $105 & 110 Calls 

GDX 09/21 $18.50-19.50 Calls


Extended Watchlist:
GALT, AMDA, ATIS, OHGI, JMU, NVDA, NFLX

Blue Horseshoe Stocks: PSID Update, Options Recap & More

PositiveID Corp. PSID

We want to look at PSID from another angle this morning as we’re noticing a situation cropping up in international media that has the potential to affect the stock and its perceived value greatly.

For the better part of four months now, there has been a rising biological threat occurring in our own hemisphere. The Zika Virus is native to sub-Saharan Africa but is currently spreading across North, Central and South America at an alarming rate, according to the World Health Organization (WHO).

Some estimates have pinned the number of potential cases as high as four million, and thus far there have been reported cases in 21 countries from Mexica to the Caribbean to Brazil, where it appears to be the greatest threat at the moment (>>View Article)

. There is no cure, no treatment, and the disease is currently thought to spread exclusively via one particular species of mosquito. The ability to detect the virus quickly and without the need for brick-and-mortar lab testing could obviously be a useful tool in eventually bringing it and its effects under control, which are admittedly terrifying. Enter PositiveID and the Firefly Dx. We witnessed a monumental run from PSID back in 2014 when the Ebola scare reached global proportions (>>View Article) and we could be seeing the beginnings of a new scare with Zika.

While Zika is a relatively mild affliction by comparison, it’s one of its main side effects that is the reason for such concern. The infected person doesn’t feel much more than flu-like symptoms, and it clears itself up without treatment in a matter of days or weeks. However, the virus has been linked to a particularly horrific birth defect known as microcephaly, wherein pregnant women are contracting the virus and subsequently giving birth to infants with malformed skulls due to lack of cerebral development. Since October, there have been at roughly 4000 reported cases in Brazil alone. The link between the virus and microcephaly isn’t yet fully understood, adding to the potential for panic.

The Zika Virus story is now making headlines worldwide, and is likely to soon become a “household name” as experts are preparing for the possibility of an actual pandemic. Given that PSID’s Firefly Dx is rapidly approaching completed development, and the fact that once released it would be the only such device that could be configured to detect Zika in a matter of minutes instead of hours, it could offer medical professionals a real edge in combating this growing health emergency.

Stay tuned for future updates on PSID. If you didn’t catch Monday’s PSID Report  we suggest checking that out now.


Options Updates

We also want to congratulate any of our subscribers who caught our excellent options ideas in yesterday’s premarket report. We’ve been striking gold on the options front all week long, and yesterday served to continue that trend.

Facebook, Inc. FB – Our idea to track FB Weekly $105-110 Calls worked out incredibly well. Regardless of which of the six strike points was chosen, enormous single-session profits were there for the taking as FB stock itself traded up from the $104 to the $110-range.

$105 Calls – Trading Range: 1.07-5.45  – Max Gain: 409%
$106 Calls – Trading Range: .78-4.55 – Max Gain: 483%
$107 Calls – Trading Range: .47-3.61 – Max Gain: 668%
$108 Calls – Trading Range: .27-2.79  – Max Gain: 933%
$109 Calls – Trading Range: .15-2.13 – Max Gain: 1320%
$110 Calls – Trading Range: .07-1.40 – Max Gain: 1900%

__________

Under Armour, Inc. UA - Our UA ideas were good as well, though they didn’t trade with quite the same liquidity and intensity as the FB options. Still, each of our monitored contracts in the range of UA Weekly $75-79.50 Calls did make appreciable intraday swings to the upside ranging from 118% ($75′s from 4.30-9.36) to 1700% in the case of the $79.50 Calls which ran from .25 to 4.62.


Extended Watchlist:
PKGM, NERG, VPRO, AMDA,

Blue Horseshoe Stocks: ITEK Recap, Options Ideas & More

Inotek Pharmaceutical Corp. ITEK

Our report for yesterday brought a couple of nice opportunities, with ITEK standing out as the most impressive. We caught this play on our routine morning scan, after noticing some abnormally elevated premarket activity. The company had released some information regarding its glaucoma treatment exiting Phase II studies and laying a strategic path for Phase III, and needless to say, it was very well-received.

This wasn’t a blink-and-you’ll-miss-it sort of move either, with just a small move up to start the session, ITEK traded sideways for most of the morning. Just prior to lunchtime is when we started to see the beginnings of an epic intraday run, especially for a stock in this price range.

From a low of  7.66, the stock exploded to reach a daily (and new annual) high of 16.75, standing as a single-session surge of 119%  The overall move as of this morning’s premarket high of 18.20 registers as an overnight increase of 138%  Cheers go out to any of our readers who caught our alert!

Inotek Pharmaceuticals Announces Positive End-of-Phase 2 Meeting with FDA and Phase 3 Development Strategy for Trabodenoson, a Novel Treatment for Glaucoma (Thu, Jul 23)


WindStream Technologies, Inc. WSTI

It was Tuesday’s Letter to Shareholders that caught our eye in the premarket news feed, causing us to raise a flag on WSTI that morning.

We’ve covered it every day since, and have been rewarded with incremental gains throughout, with the stock recording higher highs and higher lows each session. Yesterday, we witnessed an intraday run from .0172-.0244, which yielded the chance at gains of up to 42% on the day.

From our observed low on Tuesday (the 52-week low of .0085) we’ve now seen an overall jump in WSTI amounting to 187% in just three session’s time. Refer to the annotated chart below to evaluate WSTI’s chances of making further advances from this juncture.


Friday Options Ideas

If you recall last Friday, we came up huge with an alert on Weekly GOOG Calls.  We mentioned how time-decay at this point in the week begins to evaporate premiums in contracts with a weekly expiration, and generates a high-octane volatile environment where big gains are often there for the taking for those who can assume a higher-than-average risk.  A 694% intraday run from one of the sets of contracts we highlighted in that report was there to prove our point.

___

We’re going to venture a similar set of ideas this morning for Weekly AMZN Calls in the $575-595 range. The stock is gapping up hard this morning to the tune of 20%, thus we will have our eyes peeled for a classic dip-and-rip scenario.

___

We’re also going to put a marker flag on Weekly FB Calls from $96-50-97.50. The stock is rebounding off of a pullback over the past couple of days, after performing extremely well for the majority of this month.


Extended Watchlist:
AMDA, ACRX, CALA, ICLD, CRGP(news), HERO(52-wk lows)

Blue Horseshoe Stocks: PBMD Recap, ASTI News & More

Prima BioMed, Ltd. PBMD

PBMD stood out among yesterday’s fresh news plays with a solid performance on the day. It was helped along by the announcement that the European Medicines Agency had given positive Scientific Advice with regard to the development path for its metastatic breast cancer treatment.

We observed as the stock traded in a daily range from 1.42 to 1.78, representing a respectable 25% intraday swing, and it did so on the strength of nearly 3.5X its 3-month average volume.

Looking at some of the still-bullish features PBMD chart, we’re going to stay open to the possibility of seeing further upswings in the near future:


American Green, Inc. ERBB

We highlighted ERBB on Friday as a potential bottom-watch candidate, and the stock has responded with a nice move so far this week. It was trading at a low of .0039 to start things off on Monday, and yesterday we watched as it reached a .0049 high; a two-day swing of 26%

The company just completed an important step in their current business plan which was reported in a PR yesterday (link below). It was in reference to the partnership ERBB has formed to construct a legal marijuana grow operation in Colorado, which will purportedly focus solely upon the propagation of “CBD-rich cannabis strains”. It’s a story we’ll continue to follow as more details become available.


Ascent Solar Technologies, Inc. ASTI

We’re also still on alert with regard to an inclusion in Monday’s premarket report; ASTI has been making its way toward a bottom for the past few months. Yesterday we observed a low .451 toward the end of the session, and it appears that will be marked down as the the rebound point as the stock is gapping up heavily in early trading today with the help of a very positive PR.

As of this morning’s premarket high of .80 we’ve already seen a 77% swing in less than 24 hours. We’ll keep a close watch on ASTI today as this morning’s news of its 233% quarter-over-quarter revenue increase filters down and reaches more sets of eyes.


Extended Watchlist:
BTU, IPDN, UWTI, OCLS, GBSN, AMDA, CNXS(>Interesting PR)

Incoming search terms:

  • can1we
  • KW0F